Log In
BCIQ
Print this Print this
 

p38 MAP kinase inhibitor (UR-13870)

  Manage Alerts
Collapse Summary General Information
Company Palau Pharma S.A.
DescriptionP38 MAP kinase inhibitor
Molecular Target p38 mitogen-activated protein kinase (p38 MAPK) (MAPK14)
Mechanism of ActionMAP kinase (p38) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today